Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Industry News
Search Articles:
Merck Announces the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) Met
Merck announced the Trial Evaluating Cardiovascular Outcomes with Sitagliptin of Merck’s DPP-4 inhibitor, JANUVIA® (sitagliptin), achieved its primary endpoint of non-inferiority for the composite cardiovascular endpoint.
April 27, 2015
More...
Email This Page
to a Friend
Print This
Page